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Abstract
Macrophages recognize oxidatively damaged autologous erythrocytes, and cell surface fibronectin of macrophages
enhances the recognition (Beppu et al., FEBS Lett. 295 (1991) 135^140). In the present study, mechanisms of enhanced
macrophage recognition of oxidatively damaged erythrocytes by fibronectin were investigated. Monolayers of thioglycollate-
induced mouse peritoneal macrophages with cell surface fibronectin recognized autologous erythrocytes oxidized with an
iron catalyst ADP/Fe3. The macrophage recognition of the oxidized erythrocytes was inhibited partially by pretreatment of
the macrophage monolayers with a Ca2 channel blocker (diltiazem), calmodulin inhibitors (W-7, trifluoperazine,
chlorpromazine and dibucaine), an inhibitor of myosin light chain kinase (ML-9), a microfilament formation inhibitor
(cytochalasin B), phospholipase A2 inhibitors (4-bromophenacyl bromide, mepacrine) and cyclooxygenase inhibitors
(indomethacin and aspirin). Monolayers of macrophages depleted of fibronectin by trypsinization lost the ability of
recognizing oxidized erythrocytes, but acquired the ability when stimulated with a fibronectin-coated coverslip. The
recognition of fibronectin-stimulated trypsinized macrophages was also inhibited by the above inhibitors. On treatment with
Ca ionophore A23187, trypsinized macrophages acquired the ability to recognize oxidized erythrocytes. The recognition of
Ca ionophore-stimulated trypsinized macrophages was inhibited by the above inhibitors except the Ca2 channel blocker.
These results indicate that the Ca2 signaling including Ca2 influx, calmodulin activation and myosin light chain
phosphorylation are involved in the fibronectin stimulation of the recognition of macrophages for oxidized erythrocytes.
Involvement of microfilament formation and arachidonate cascade in the fibronectin stimulation was also
suggested. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Oxidative damage of cells involved in lipid and
protein oxidation is one of the possible means of
cellular damages that can take place in vivo [1^3].
Binding of autologous anti-band 3 IgG to the cell
surface sugar chains of band 3 protein aggregates
generated during aging or oxidative damage of hu-
man erythrocytes has been suggested to be involved
in the removal of the cells from the circulation [4]. In
addition, recognition of oxidatively damaged eryth-
rocytes in the circulation by macrophages is an im-
portant event for phagocytic removal of e¡ete or
0167-4889 / 01 / $ ^ see front matter ß 2001 Elsevier Science B.V. All rights reserved.
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senescent erythrocytes from the circulation [5,6]. We
have found that mouse macrophages selectively rec-
ognize oxidatively damaged erythrocytes in the ab-
sence of serum [7^9].
Macrophages have the receptors, members of the
integrin family [10^12], for ¢bronectin, an adhesive
glycoprotein on the surface of many types of cells
and in extracellular matrices and plasma. Fibronectin
is detected on thioglycollate-induced mouse perito-
neal macrophages [13], and it has been shown that
cell surface ¢bronectin plays an important role in the
opsonin-independent macrophage recognition of oxi-
datively damaged erythrocytes [14]. Macrophages
plated on a coverslip precoated with ¢bronectin are
found to be more active in recognizing the oxidized
erythrocytes, and those depleted of cell surface ¢bro-
nectin by trypsinization lose their recognizing ability.
The e¡ect of ¢bronectin is shown to be due to spe-
ci¢c binding of Arg-Gly-Asp (RGD)-containing tri-
peptide sequence of ¢bronectin to the ¢bronectin re-
ceptors on the macrophage surface.
In the present study, in order to elucidate the role
of ¢bronectin in the thioglycollate-induced macro-
phage recognition of oxidatively damaged erythro-
cytes, we investigated the e¡ect of Ca2 signaling
on the ¢bronectin-stimulated recognition activity of
the mouse macrophages for the oxidized mouse er-
ythrocytes. We will report here that ¢bronectin-
stimulated Ca2 signaling was involved in the ¢bro-
nectin-stimulated macrophage recognition of the oxi-
datively damaged erythrocytes.
2. Materials and methods
2.1. Materials
ADP monopotassium salt was purchased from
Oriental Yeast (Tokyo). Trypsin (bovine pancreas,
223 units/mg) was obtained from Worthington Bio-
chemical (Freehold, NJ). Hanks’ balanced salt solu-
tion (HBSS) and N-2-hyroxyethylpiperazine-NP-2-
ethanesulfonic acid (HEPES) were obtained from
Nissui Pharmaceutical (Tokyo) and Dojindo (Kuma-
moto), respectively. RPMI 1640 medium and penicil-
lin-streptomycin solution were obtained from Gibco
(Grand Island, NY). Soybean trypsin inhibitor (type
I-S), calmodulin inhibitor tri£uoperazine dihydro-
chloride and Ca ionophore A23187 were purchased
from Sigma (St. Louis, MO). Ca2 channel blocker
diltiazem hydrochloride, calmodulin inhibitor chlor-
promazine hydrochloride, cyclooxygenase inhibitors
indomethacin and aspirin, phospholipase A2 inhibi-
tors 4-bromophenacyl bromide (BPB) and quinacrine
dihydrochloride (mepacrine), and calmodulin inhibi-
tor dibucaine hydrochloride were obtained from
Wako Pure Chemical Industries (Osaka). Calmodu-
lin inhibitor W-7, protein kinase C inhibitor H-7,
myosin light chain kinase inhibitor ML-9 and micro-
¢lament formation inhibitor cytochalasin B were ob-
tained from Seikagaku (Tokyo).
Plasma ¢bronectin was puri¢ed from pooled hu-
man plasma by a⁄nity chromatography on gelatin-
Sepharose 4B columns according to the method of
Engvall and Ruoslahti [15] with minor modi¢cations
as described [10]. Puri¢ed plasma ¢bronectin was
stored in 10 mM phosphate bu¡er/0.15 M sodium
chloride (pH 7.2) containing 0.02% sodium azide,
at 4‡C, and used within a month. Plasma ¢bronectin
concentration was determined spectrophotometri-
cally using E (1%, 1 cm) at 280 nm = 12.8 [16].
2.2. Coating coverslip with ¢bronectin
A round glass coverslip (18 mm diameter) that had
been treated with 5% nitric acid at 100‡C for 45 min
was loaded with 0.2 ml of a solution of ¢bronectin
(67 Wg/ml) in 10 mM phosphate bu¡er (pH 7.2).
After standing for more than 2 h, the coverslip was
rinsed several times with Dulbecco’s phosphate-bu¡-
ered saline (DPBS) and used immediately.
2.3. Macrophages
Macrophages were obtained from the peritoneal
cavity of 7^10-week-old male ddY mice 4 days after
an intraperitoneal injection of 2^3 ml of 3% thiogly-
collate medium (Difco, Detroit, MI). The perito-
neal exudate cells obtained were washed twice with
HBSS by centrifugation (80Ug, 10 min) at 4‡C. The
cells were resuspended at appropriate concentrations
in RPMI 1640 medium supplemented with 20 mM
HEPES (pH 7.2), 50 units/ml penicillin and 50 Wg/ml
streptomycin (RPMI-HEPES medium) at 1^1.5U106
cells/ml.
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2.4. Trypsinization of macrophages
A macrophage suspension in RPMI-HEPES me-
dium (1^1.5U106 cells/ml) was incubated with tryp-
sin (100 Wg/ml) at 25‡C for 30 min, centrifuged
(80Ug, 10 min) at 4‡C, and the supernatant was
removed. A solution of soybean trypsin inhibitor
(100 Wg/ml) in RPMI-HEPES medium was added
to the cell pellet, and the cell suspension was allowed
to stand for 10 min at room temperature to ensure
the quenching of the proteolysis. The cells were
washed twice with Ca2-, Mg2-free DPBS
(DPBS(3)), and resuspended in RPMI-HEPES me-
dium (2U106 cells/ml).
2.5. Macrophage monolayer
The cell suspension (0.2 ml) of macrophages or
trypsinized macrophages was loaded onto a round
glass coverslip (18 mm diameter) plain or one that
had been coated by ¢bronectin. After incubation at
37‡C for 1 h, non-adherent cells were removed by
washing three times with DPBS(3), and adherent
monolayers were subjected to the assay for erythro-
cyte recognition. More than 80% of the cells were
macrophages as de¢ned by phagocytosis of latex par-
ticles (0.8 Wm, Difco) and sheep erythrocytes sensi-
tized with a subhemagglutinating dose of rabbit anti-
sheep erythrocyte IgG [14]. The cell density of the
monolayers was not signi¢cantly di¡erent from that
of intact macrophages.
2.6. Erythrocytes
Erythrocytes were obtained from the same mouse
individuals from which macrophages were obtained.
Mouse blood was collected by cardiac puncture using
an acid-citrate-dextrose preservative solution, and er-
ythrocytes were isolated. Oxidized erythrocytes were
obtained according to the method previously de-
scribed [14]. An erythrocyte suspension (20% hemat-
ocrit) in DPBS was mixed with an equal volume of a
solution of 3.4 mM ADP/0.2 mM FeCl3 in 0.15 M
sodium chloride, and incubated at 37‡C for 1 h with
gentle shaking. The cells were collected by centrifu-
gation (650Ug, 5 min), washed three times with
DPBS, and resuspended in RPMI-HEPES medium
at a concentration of 2%. Control cells were prepared
in a similar manner and incubated at 37‡C for 1 h in
the same bu¡er.
2.7. Assay for the macrophage recognition
For the investigation of the e¡ect of the inhibitors
on the recognition of the ¢bronectin-stimulated mac-
rophages, the macrophage monolayer on a plain cov-
erslip or the trypsinized macrophage monolayer on a
¢bronectin-precoated coverslip was incubated with a
200 Wl solution of each of the inhibitors in RPMI-
HEPES medium at the indicated concentration at
37‡C for 1 h. The monolayer was washed three times
with DPBS(3). For the investigation of the e¡ect of
the inhibitors on the recognition of the Ca iono-
phore-stimulated macrophages, the trypsinized mac-
rophage monolayer on a plain coverslip was incu-
bated with a 200 Wl solution of 0.1 WM Ca
ionophore A23187 in RPMI-HEPES medium at
37‡C for 2 h. The monolayer was washed three times
with DPBS(3). The monolayer was immediately
treated with a 200 Wl solution of each of the inhib-
itors at 37‡C for 1 h followed by washing with
DPBS(3).
A 2% cell suspension of erythrocytes (200 Wl) in
RPMI-HEPES medium was added to the macro-
phage monolayer. After incubation at 37‡C for 1 h,
non-adhering erythrocytes were removed by gentle
washing with DPBS(3). The monolayer was ¢xed
with 1.25% glutaraldehyde. The number of the mac-
rophages binding one or more erythrocytes on their
surface was scored for the random ¢elds of the cov-
erslip under a phase contrast microscope. At least
200 macrophages were examined for binding of er-
ythrocytes, and the percentage of macrophages that
bound one or more erythrocytes (% adhesion) was
determined. The results were expressed as the mean
of the triplicate experiments.
3. Results
Thioglycollate-induced mouse peritoneal macro-
phage monolayer recognized autologous mouse er-
ythrocytes oxidized with an iron catalyst ADP/Fe3
at 1.7 mM/0.1 mM and 37‡C for 1 h more e¡ectively
than unoxidized erythrocytes. The percentages of the
number of macrophages that recognized oxidized
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Fig. 1. Inhibition of adhesion of oxidized erythrocytes to a monolayer of macrophages by Ca2 signal inhibitors, Ca2 channel block-
er (A), calmodulin inhibitor (B) and myosin light chain kinase inhibitor (C). A thioglycollate-induced mouse peritoneal macrophage
suspension was plated on a coverslip at 37‡C for 1 h, and the resultant macrophage monolayer was treated with 200 Wl of the solution
of each of the inhibitors at 37‡C for 1 h followed by the assay for adhesion of oxidized mouse erythrocytes at 37‡C for 1 h. The per-
centages of the number of macrophages that adhered to oxidized erythrocytes were 30-40%, and those that adhered to unoxidized er-
ythrocytes were 10-20%. The macrophage adhesion ratio of oxidized erythrocytes in the absence of the inhibitors was made 100. The
level of macrophage adhesion for unoxidized erythrocytes was not a¡ected in the presence of the inhibitors, and the dotted line indi-
cates the level of macrophage adhesion of unoxidized erythrocytes.
Fig. 2. Inhibition of adhesion of oxidized erythrocytes to a monolayer of macrophages by arachidonate cascade inhibitors, phospholi-
pase A2 inhibitors (A) and cyclooxygenase inhibitors (B). Details are the same as in the legend of Fig. 1.
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erythrocytes were 30^40%, whereas those recognized
unoxidized erythrocytes were 10^20%. The macro-
phage recognition was lowered by depletion of the
cell surface ¢bronectin by trypsinization, and the
ability of recognition was recovered by pretreatment
of the trypsinized macrophage monolayer with ¢bro-
nectin precoated on the coverslip. The percentages of
the number of ¢bronectin-stimulated trypsinized
macrophages that recognized oxidized erythrocytes
were 30^40%, whereas those of the unstimulated
trypsinized macrophages that recognized oxidized er-
ythrocytes were 10^20%. These observations were
consistent with those in the previous studies [14].
E¡ect of pretreatment of the intact macrophage
monolayers with the inhibitors of Ca2 signaling on
the recognition of oxidized erythrocytes was exam-
ined (Fig. 1). The macrophage recognition of oxi-
dized erythrocytes was decreased by pretreatment
of the macrophage monolayers with a Ca2 channel
blocker, diltiazem, in a dose-dependent manner (Fig.
1A). By contrast, the recognition of unoxidized
Fig. 3. Inhibition of adhesion of oxidized erythrocytes to a
monolayer of macrophages by protein kinase C inhibitor (A)
and micro¢lament formation inhibitor (B). Details are the same
as in the legend of Fig. 1.
Fig. 4. Inhibition of adhesion of oxidized erythrocytes to a monolayer of ¢bronectin-stimulated trypsinized macrophages by Ca2 sig-
nal inhibitors, Ca2 channel blocker (A), calmodulin inhibitor (B) and myosin light chain kinase inhibitor (C). A trypsinized thiogly-
collate-induced mouse peritoneal macrophage suspension was plated on a ¢bronectin coated-coverslip at 37‡C for 1 h, and the resul-
tant macrophage monolayer was treated with 200 Wl of the solution of each of the inhibitors at 37‡C for 1 h followed by the assay
for adhesion of oxidized mouse erythrocytes at 37‡C for 1 h. The percentages of the number of ¢bronectin-stimulated trypsinized mac-
rophages that adhered to oxidized erythrocytes were 30-40%, and those of ¢bronectin-unstimulated trypsinized macrophages were 10-
20%. The macrophage adhesion ratio of oxidized erythrocytes in the absence of the inhibitors was made 100. The level of ¢bronectin-
unstimulated trypsinized macrophage adhesion for unoxidized erythrocytes was not a¡ected in the presence of the inhibitors, and the
dotted line indicates the level of ¢bronectin-unstimulated trypsinized macrophages.
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erythrocytes in the lower level was unchanged by the
diltiazem pretreatment. The macrophage recognition
of oxidized erythrocytes was decreased by the pre-
treatment with 100 WM diltiazem to about 50% of
the recognition obtained without the pretreatment.
The depressed level of the macrophage recognition
of oxidized erythrocytes with 100 WM diltiazem was
similar to the level of recognition of unoxidized er-
ythrocytes (Fig. 1A, dotted line). The macrophage
recognition of oxidized erythrocytes was decreased
by pretreatment with calmodulin inhibitors, W-7, tri-
£uoperazine, chlorpromazine and dibucaine, in dose-
dependent manners, whereas that of unoxidized er-
ythrocytes was not a¡ected by the pretreatment (Fig.
1B). The recognition of oxidized erythrocytes was
decreased by pretreatment with a myosin light chain
kinase inhibitor, ML-9 (Fig. 1C), in a dose-depen-
dent manner, whereas that of unoxidized erythro-
cytes was not a¡ected by the pretreatment.
E¡ect of pretreatment of the intact macrophage
monolayers with the inhibitors of arachidonate cas-
cade on the recognition of oxidized erythrocytes was
examined (Fig. 2). The macrophage recognition of
oxidized erythrocytes was decreased by pretreatment
of the macrophage monolayers with phospholipase
Fig. 5. Inhibition of adhesion of oxidized erythrocytes to a monolayer of ¢bronectin-stimulated trypsinized macrophages by arachi-
donate cascade inhibitors, phospholipase A2 inhibitors (A) and cyclooxygenase inhibitors (B). Details are the same as in the legend of
Fig. 4.
Fig. 6. Inhibition of adhesion of oxidized erythrocytes to a
monolayer of ¢bronectin-stimulated trypsinized macrophages by
protein kinase C inhibitor (A) and micro¢lament formation in-
hibitor (B). Details are the same as in the legend of Fig. 4.
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A2 inhibitors, BPB and mepacrine (Fig. 2A), and
with cyclooxygenase inhibitors, indomethacin and as-
pirin (Fig. 2B), in dose-dependent manners, whereas
that of unoxidized erythrocytes was not a¡ected by
the pretreatments.
The recognition of oxidized erythrocytes was not
decreased by a protein kinase C inhibitor, H-7, even
at the concentration at 100 WM (Fig. 3A), and the
recognition was decreased by pretreatment with a
micro¢lament formation inhibitor, cytochalasin B,
in a dose-dependent manner (Fig. 3B).
Fig. 7. Enhancement of adhesion of oxidized erythrocytes to a
monolayer of trypsinized macrophages by Ca ionophore
A23187. An intact (a) or a trypsinized (b) thioglycollate-in-
duced mouse peritoneal macrophage suspension was plated on
a coverslip at 37‡C for 1 h, and the resultant macrophage
monolayer was treated with 200 Wl of 0.1 WM Ca ionophore
A23187 solution at 37‡C for the indicated period followed by
the assay for adhesion of oxidized mouse erythrocytes at 37‡C
for 1 h.
6
Fig. 8. Inhibition of adhesion of oxidized erythrocytes to a monolayer of Ca ionophore A23187-stimulated trypsinized macrophages
by Ca2 signal inhibitors, Ca2 channel blocker (A), calmodulin inhibitor (B) and myosin light chain kinase inhibitor (C). A trypsi-
nized thioglycollate-induced mouse peritoneal macrophage suspension was plated on a coverslip at 37‡C for 1 h, and the resultant
macrophage monolayer was treated with 200 Wl of 0.1 WM Ca ionophore A23187 solution at 37‡C for 2 h followed by treatment with
the solution of each of the inhibitors at 37‡C for 1 h. The assay for adhesion of oxidized mouse erythrocytes was conducted at 37‡C
for 1 h. The percentages of the number of A23187-stimulated trypsinized macrophages that adhered to oxidized erythrocytes were 30-
40%, and those of unstimulated trypsinized macrophages were 10-20%. The macrophage adhesion ratio of oxidized erythrocytes in the
absence of the inhibitors was made 100. The level of Ca ionophore-unstimulated trypsinized macrophage adhesion of unoxidized er-
ythrocytes was not a¡ected in the presence of the inhibitors, and the dotted line indicates the level of Ca ionophore-unstimulated tryp-
sinized macrophages.
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The recognition of oxidized erythrocytes by ¢bro-
nectin-stimulated trypsinized macrophages was also
inhibited by the Ca2 channel blocker (Fig. 4A), the
calmodulin inhibitors (Fig. 4B) and the myosin light
chain kinase inhibitor (Fig. 4C). The levels of the
recognition reached those of the recognition by ¢bro-
nectin-unstimulated trypsinized macrophages. The
recognition by ¢bronectin-stimulated trypsinized
macrophages was slightly inhibited by the phospho-
lipase A2 inhibitors (Fig. 5A) and also inhibited by
the cyclooxygenase inhibitors (Fig. 5B). The recogni-
tion was not inhibited by the protein kinase C inhib-
itor (Fig. 6A), and the recognition was decreased by
pretreatment with the micro¢lament formation inhib-
itor in a dose-dependent manner (Fig. 6B). The re-
sults were similar to those obtained from intact mac-
rophages (Figs. 1^3).
It was found that macrophages depleted of ¢bro-
nectin by trypsinization acquired the ability of rec-
ognition of oxidized erythrocytes on treatment with
Ca ionophore A23187. Fig. 7 shows that incubation
of the monolayer of trypsinized macrophages with
0.1 WM Ca ionophore A23187 at 37‡C for more
than 1 h increased the recognition by 2-fold, whereas
the incubation of the monolayer of intact macro-
phages with Ca ionophore did not increase the rec-
ognition. Increased Ca ionophore-stimulated recog-
nition was lost 5 h after washing out the ionophore,
indicating that the augmentation was reversible (data
not shown). Hence, Ca2 in£ux into the macrophage
cells was important for the recognition of ¢bronec-
tin-stimulated macrophages for oxidized erythro-
cytes.
Inhibitory e¡ects of several inhibitors on the Ca
ionophore-stimulated trypsinized macrophage recog-
nition of oxidized erythrocytes were examined. The
recognition was not inhibited by the Ca2 channel
blocker (Fig. 8A), but the recognition was inhibited
by each of the calmodulin inhibitors (Fig. 8B) and
the myosin light chain kinase inhibitor (Fig. 8C). The
level of recognition reached to the level of the Ca
ionophore-unstimulated trypsinized macrophages.
While this recognition was not inhibited by the phos-
pholipase A2 inhibitors (Fig. 9A), it was inhibited by
the cyclooxygenase inhibitors (Fig. 9B).
4. Discussion
It has been shown that thioglycollate-induced
mouse peritoneal macrophages plated on a coverslip
precoated with ¢bronectin are more active in binding
Fig. 9. Inhibition of adhesion of oxidized erythrocytes to a monolayer of Ca ionophore A23187-stimulated trypsinized macrophages
by arachidonate cascade inhibitors, phospholipase A2 inhibitors (A) and cyclooxygenase inhibitors (B). Details are the same as in the
legend of Fig. 8.
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oxidized erythrocytes [14]. This e¡ect of the ¢bronec-
tin-precoated coverslip is found to be due to speci¢c
binding of a RGD-containing sequence of ¢bronectin
to the ¢bronectin receptors on the macrophages. Re-
moval of ¢bronectin originally present on the macro-
phage surface by trypsinization, prior to attachment
to the unprecoated coverslip, results in diminution of
their ability of recognition of oxidized erythrocytes,
but the diminished ability is restored when trypsi-
nized macrophages are plated on a ¢bronectin-pre-
coated coverslip, indicating that the cell surface ¢-
bronectin is e¡ective for the macrophage recognition.
In the present study, we found that Ca2 signaling
was involved in the enhancement of the ¢bronectin-
stimulated recognition for oxidized erythrocytes.
This was clearly demonstrated by the following lines
of evidence. The recognition of oxidized erythrocytes
by the monolayers of intact macrophages attached to
the plain coverslip or trypsinized macrophages at-
tached to the ¢bronectin-precoated coverslip was in-
hibited by the pretreatment of the monolayers with
Ca2 signal inhibitors, the Ca2 channel blocker, cal-
modulin inhibitors and the myosin light chain kinase
inhibitor (Figs. 1 and 4). The recognition of oxidized
erythrocytes by the monolayers of trypsinized macro-
phages attached to the plain coverslip was enhanced
by Ca ionophore A23187 (Fig. 7), and the Ca ion-
ophore-stimulated recognition was inhibited by cal-
modulin inhibitors and the myosin light chain kinase
inhibitor (Fig. 8). The Ca2 channel, calmodulin and
myosin light chain kinase inhibitors appeared to in-
hibit the e¡ect of ¢bronectin selectively because these
inhibitors did not inhibit the recognition of the abil-
ity of the ¢bronectin-unstimulated or Ca ionophore-
unstimulated trypsinized macrophages (Figs. 4 and
8).
There are several lines of evidence showing that
calcium ions participate in the signal transduction
into the cells through the receptors on the cell sur-
face. Integrins including ¢bronectin receptors have
been shown to transmit biochemical signals into the
cells upon binding at the extracelluar sites with the
adhesion molecules [17,18]. Elevation of intracellular
free Ca2 upon binding with integrin ligands includ-
ing ¢bronectin has been reported for endothelial cells
[19,20], epithelial cells [21] and platelets [22]. Inhibi-
tion by the Ca2 channel blocker of the ¢bronectin-
stimulated macrophage recognition of oxidized er-
ythrocytes observed here (Figs. 1 and 3) indicates
that the binding of ¢bronectin to the ¢bronectin re-
ceptors on the surface of the macrophages elevated
the Ca2 in£ux. This was consistent with the obser-
vation that Ca2 in£ux elevated by Ca ionophore
activated the recognition of ¢bronectin-unstimulated
trypsinized macrophages (Fig. 7). Intracellular free
Ca2 may be elevated in the ¢bronectin-stimulated
macrophages because the calmodulin inhibitors in-
hibit the recognition of oxidized erythrocytes.
It is likely that arachidonate cascade, phospholi-
pase A2 and cyclooxygenase, was also involved in the
¢bronectin-stimulated recognition because their in-
hibitors prevented the ¢bronectin-stimulated recogni-
tion (Figs. 2 and 4). While the Ca ionophore-stimu-
lated recognition was not inhibited by the
phospholipase A2 inhibitors, it was inhibited by the
cyclooxygenase inhibitors (Fig. 9). This result indi-
cates that the activation of arachidonate cascade by
¢bronectin was not always through Ca2 signaling.
Activation of the arachidonate cascade by ¢bronec-
tin may be an independent pathway from Ca2 sig-
naling. Formation of micro¢lament from actin may
also be involved in the ¢bronectin-stimulated recog-
nition of oxidized erythrocytes (Figs. 3 and 6).
In the recognition of mouse thioglycollate-induced
macrophages for mouse erythrocytes oxidized with
an iron catalyst, aggregated poly-N-acetyllactosamin-
yl saccharide chains of band 3 protein are suggested
to be involved [9]. The receptor on the macrophage
surface for oxidized erythrocytes may be the lacto-
ferrin receptor, which has been found on the surface
of human macrophages [23^25]. Fibronectin- or Ca
ionophore-unstimulated trypsinized macrophage rec-
ognition of oxidized erythrocytes observed here
(Figs. 4, 5, 8 and 9) may be due to the lactoferrin
receptor on the macrophage surface. However, Ca2
signaling stimulated by ¢bronectin or Ca ionophore,
observed here, may not be due to the activation of
the above lactoferrin receptor, because the inhibitors
did not inhibit the recognition ability of the ¢bronec-
tin- or Ca ionophore-unstimulated trypsinized mac-
rophages. It is likely that in the ¢bronectin- and the
Ca ionophore-stimulated macrophages, one or more
other speci¢c receptors for oxidized erythrocytes are
created.
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